AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Macias-Matos, C.
Right arrow Articles by Bates, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macias-Matos, C.
Right arrow Articles by Bates, C. J.
Agricola
Right arrow Articles by Macias-Matos, C.
Right arrow Articles by Bates, C. J.

American Journal of Clinical Nutrition, Vol 64, 347-353, Copyright © 1996 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Biochemical evidence of thiamine depletion during the Cuban neuropathy epidemic, 1992-1993

C Macias-Matos, A Rodriguez-Ojea, N Chi, S Jimenez, D Zulueta and CJ Bates
Institute of Nutrition and Food Hygiene, Havana.

During an epidemic outbreak of neuropathy in Cuba during 1992-1993, blood and urine samples were collected from 107 persons with confirmed neuropathy, from 106 control subjects without clinical abnormality who were broadly matched with the affected persons by age and domicile, and from 537 unmatched subjects, also free from clinical abnormality. The unmatched subjects lived in two locations in Cuba; at each location they were drawn from two age ranges: 11-15-y-old secondary school students and 16-64-y-old adults. Measurements of urinary thiamine and blood transketolase and its activation with thiamine pyrophosphate were made. For the neuropathy subjects, these measurements were repeated after 3 wk of rehabilitation. All groups showed biochemical evidence of thiamine depletion affecting 30-70% of their members, which is a high prevalence. Severity of biochemical depletion was, however, no greater in the neuropathy subjects than in the control subjects (P > 0.05). However, it was greater in Pinar del Rio, where the incidence of disease was higher, than in the city of Havana, where less disease was seen. Although the majority of the affected subjects responded biochemically to a daily oral multivitamin supplement containing thiamine (P < 0.001), in some cases normal biochemical status was not achieved even after 3 wk of intensive treatment. In the affected group, thiamine status was inversely correlated with the amount of alcohol consumed (P = 0.007). Thiamine status at the outset was correlated with clinical outcome after treatment. Although neither thiamine depletion nor alcohol abuse were likely to have been the sole cause of the neuropathy epidemic, they may have been contributory factors. Thiamine supplementation or food fortification may therefore be necessary in Cuba.


This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
D. Lonsdale
A Review of the Biochemistry, Metabolism and Clinical Benefits of Thiamin(e) and Its Derivatives.
Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 49 - 59.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. McLaren Howard, D. Talwar, and D. St. JO'Reilly
Assessment of Vitamin B1 Status
Clin. Chem., November 1, 2000; 46(11): 1867 - 1868.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by The American Society for Nutrition